ENERGI-F703
/ Energenesis Biomedical
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 03, 2025
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
(clinicaltrials.gov)
- P3 | N=230 | Recruiting | Sponsor: Energenesis Biomedical Co., Ltd. | Trial completion date: Dec 2025 ➔ Mar 2026 | Trial primary completion date: Sep 2025 ➔ Dec 2025
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders
December 09, 2024
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
(clinicaltrials.gov)
- P3 | N=230 | Recruiting | Sponsor: Energenesis Biomedical Co., Ltd. | Trial completion date: Dec 2024 ➔ Dec 2025 | Trial primary completion date: Jul 2024 ➔ Sep 2025
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders
July 05, 2023
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
(clinicaltrials.gov)
- P3 | N=230 | Recruiting | Sponsor: Energenesis Biomedical Co., Ltd.
New P3 trial • Diabetes • Metabolic Disorders
1 to 3
Of
3
Go to page
1